How to Select Patients for Left Ventricular Assist Devices? A Guide for Clinical Practice

In recent years, a significant improvement in left ventricular assist device (LVAD) technology has occurred, and the continuous-flow devices currently used can last more than 10 years in a patient. Current studies report that the 5-year survival rate after LVAD implantation approaches that after a h...

Descripción completa

Detalles Bibliográficos
Autores principales: Masarone, Daniele, Houston, Brian, Falco, Luigi, Martucci, Maria L., Catapano, Dario, Valente, Fabio, Gravino, Rita, Contaldi, Carla, Petraio, Andrea, De Feo, Marisa, Tedford, Ryan J., Pacileo, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455625/
https://www.ncbi.nlm.nih.gov/pubmed/37629257
http://dx.doi.org/10.3390/jcm12165216
Descripción
Sumario:In recent years, a significant improvement in left ventricular assist device (LVAD) technology has occurred, and the continuous-flow devices currently used can last more than 10 years in a patient. Current studies report that the 5-year survival rate after LVAD implantation approaches that after a heart transplant. However, the outcome is influenced by the correct selection of the patients, as well as the choice of the optimal time for implantation. This review summarizes the indications, the red flags for prompt initiation of LVAD evaluation, and the principles for appropriate patient screening.

Ejemplares similares